InsidersTradesSigma
Total declarations
Company
▲ Purchases (0 ops.)
▼ Sales (2 ops.)
Discover the complete record of transactions filed by McGrath Lynne Fahey, Director. Insider active across 1 companies, notably Alzamend Neuro, Inc.. Aggregated, 7 disclosures have been logged. Total volume traded: €55k. The latest transaction was filed on 28 March 2022 — Cession. Regulator: SEC (Form 4). All data is openly available.
Declarations7 total
€27,58425,000 shares@ €1.10330.60% mcap50.0% of flow
Common Stock
SEC:0001214659-22-004992:0·
€27,58425,000 shares@ €1.10330.60% mcap50.0% of flow
Common Stock
SEC:0001214659-22-004914:0·
050,000 shares0
Common Stock
SEC:0001214659-22-003986:0·
047,222 shares0
Common Stock
SEC:0001214659-21-010561·
047,222 shares0
Common Stock
SEC:0001214659-21-010561:0·
02,778 shares0
Common Stock
SEC:0001214659-21-009540·
02,778 shares0
Common Stock
SEC:0001214659-21-009540:0·
7 of 7 declarations
About McGrath Lynne Fahey
McGrath Lynne Fahey is a Board Member at Alzamend Neuro, Inc. In this role, she participates in overseeing the company's activities and making strategic decisions. Lynne brings her expertise to guide the direction of Alzamend and ensure compliance with governance standards. Her commitment to operational excellence is a valuable asset to the board.
